Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.
Ron IG, Wigler N, Borovik R, Peretz T, Rizel S, Shani A, Brenner J, Farbstein H, Brenner HJ, Chaitchik S, Catane R, Inbar MJ. Ron IG, et al. Among authors: borovik r. Am J Clin Oncol. 2002 Oct;25(5):520-2. doi: 10.1097/00000421-200210000-00020. Am J Clin Oncol. 2002. PMID: 12393997 Clinical Trial.
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study.
Ron IG, Wigler N, Borovik R, Brufman G, Rizel S, Shani A, Brenner J, Farbstein H, Dale A, Inbar MJ, Brenner HJ, Chaitchik S, Catane R. Ron IG, et al. Among authors: borovik r. Am J Clin Oncol. 2001 Aug;24(4):323-7. doi: 10.1097/00000421-200108000-00001. Am J Clin Oncol. 2001. PMID: 11474254 Clinical Trial.
[Treatment of stage I malignant melanoma].
Fried G, Stein M, Borovik R, Ben Shachar M, Robinson E. Fried G, et al. Among authors: borovik r. Harefuah. 1989 Sep;117(5-6):130-3. Harefuah. 1989. PMID: 2485754 Hebrew.
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page